241 related articles for article (PubMed ID: 34980178)
41. Advanced nasopharyngeal carcinoma radiotherapy with volumetric modulated arcs and the potential role of flattening filter-free beams.
Zhuang M; Zhang T; Chen Z; Lin Z; Li D; Peng X; Qiu Q; Wu R
Radiat Oncol; 2013 May; 8():120. PubMed ID: 23672519
[TBL] [Abstract][Full Text] [Related]
42. Vertebral artery sparing volumetric modulated arc therapy in nasopharyngeal carcinoma.
Lu SH; Lan HT; Tsai YC; Chen YF; Lai SF; Liang HK; Huang BS; Chen WY; Wang CW
Med Dosim; 2023 Winter; 48(4):304-311. PubMed ID: 37673726
[TBL] [Abstract][Full Text] [Related]
43. A dosimetric comparison of the use of equally spaced beam (ESB), beam angle optimization (BAO), and volumetric modulated arc therapy (VMAT) in head and neck cancers treated by intensity modulated radiotherapy.
Leung WS; Wu VWC; Liu CYW; Cheng ACK
J Appl Clin Med Phys; 2019 Nov; 20(11):121-130. PubMed ID: 31593367
[TBL] [Abstract][Full Text] [Related]
44. Treatment planning comparison of volumetric modulated arc therapy with the trilogy and the Halcyon for bilateral breast cancer.
Sun T; Lin X; Zhang G; Qiu Q; Li C; Yin Y
Radiat Oncol; 2021 Feb; 16(1):35. PubMed ID: 33602267
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of optimal treatment planning for radiotherapy of synchronous bilateral breast cancer including regional lymph node irradiation.
Cho Y; Cho YJ; Chang WS; Kim JW; Choi WH; Lee IJ
Radiat Oncol; 2019 Apr; 14(1):56. PubMed ID: 30935400
[TBL] [Abstract][Full Text] [Related]
46. Small-spot intensity-modulated proton therapy and volumetric-modulated arc therapies for patients with locally advanced non-small-cell lung cancer: A dosimetric comparative study.
Liu C; Sio TT; Deng W; Shan J; Daniels TB; Rule WG; Lara PR; Korte SM; Shen J; Ding X; Schild SE; Bues M; Liu W
J Appl Clin Med Phys; 2018 Nov; 19(6):140-148. PubMed ID: 30328674
[TBL] [Abstract][Full Text] [Related]
47. Dosimetric study of uniform scanning proton therapy planning for prostate cancer patients with a metal hip prosthesis, and comparison with volumetric-modulated arc therapy.
Rana S; Cheng C; Zheng Y; Hsi W; Zeidan O; Schreuder N; Vargas C; Larson G
J Appl Clin Med Phys; 2014 May; 15(3):4611. PubMed ID: 24892333
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of deformed image-based dose calculations for adaptive radiotherapy of nasopharyngeal carcinoma.
Poon M; Holborn C; Cheng KF; Fung WWK; Chiu G
Med Dosim; 2017 Winter; 42(4):273-281. PubMed ID: 28781156
[TBL] [Abstract][Full Text] [Related]
49. Volumetric modulated arc therapy treatment planning of thoracic vertebral metastases using stereotactic body radiotherapy.
Mallory M; Pokhrel D; Badkul R; Jiang H; Lominska C; Wang F
J Appl Clin Med Phys; 2018 Mar; 19(2):54-61. PubMed ID: 29349867
[TBL] [Abstract][Full Text] [Related]
50. Radiobiological impact of dose calculation algorithms on biologically optimized IMRT lung stereotactic body radiation therapy plans.
Liang X; Penagaricano J; Zheng D; Morrill S; Zhang X; Corry P; Griffin RJ; Han EY; Hardee M; Ratanatharathom V
Radiat Oncol; 2016 Jan; 11():10. PubMed ID: 26800883
[TBL] [Abstract][Full Text] [Related]
51. A treatment planning study comparing Elekta VMAT and fixed field IMRT using the varian treatment planning system eclipse.
Peters S; Schiefer H; Plasswilm L
Radiat Oncol; 2014 Jul; 9():153. PubMed ID: 25011529
[TBL] [Abstract][Full Text] [Related]
52. Ultra hypofractionated extended nodal irradiation using volumetric modulated arc therapy for oligorecurrent pelvic nodal prostate cancer.
Slevin F; Thompson CM; Speight R; Murray LJ; Lilley J; Henry AM
Med Dosim; 2021 Winter; 46(4):411-418. PubMed ID: 34148727
[TBL] [Abstract][Full Text] [Related]
53. Feasibility of a Skin Dose Reduction for Nasopharyngeal Carcinoma Treated With High-Intensity-Modulated Delivery Techniques.
Liao X; Li J; Wang P; Yao X; Zhang Y; Tan T; Orlandini LC
Technol Cancer Res Treat; 2018 Jan; 17():1533033818803582. PubMed ID: 30343642
[TBL] [Abstract][Full Text] [Related]
54. Volumetric intensity-modulated arc therapy vs conventional intensity-modulated radiation therapy in nasopharyngeal carcinoma: a dosimetric study.
White P; Chan KC; Cheng KW; Chan KY; Chau MC
J Radiat Res; 2013 May; 54(3):532-45. PubMed ID: 23188186
[TBL] [Abstract][Full Text] [Related]
55. Cochlea sparing optimized radiotherapy for nasopharyngeal carcinoma.
Lamaj E; Vu E; van Timmeren JE; Leonardi C; Marc L; Pytko I; Guckenberger M; Balermpas P
Radiat Oncol; 2021 Apr; 16(1):64. PubMed ID: 33794949
[TBL] [Abstract][Full Text] [Related]
56. [Study on the assignment method of intensity modulated radiotherapy plan for nasopharyngeal carcinoma based on MR images].
Yao XS; Gong GZ; Ren JX; Zuo GP; Yin Y
Zhonghua Zhong Liu Za Zhi; 2021 Aug; 43(8):850-855. PubMed ID: 34407590
[No Abstract] [Full Text] [Related]
57. A comparative dosimetric study of left sided breast cancer after breast-conserving surgery treated with VMAT and IMRT.
Zhao H; He M; Cheng G; Han D; Wu N; Shi D; Zhao Z; Jin J
Radiat Oncol; 2015 Nov; 10():231. PubMed ID: 26577189
[TBL] [Abstract][Full Text] [Related]
58. Dosimetric comparison of intensity modulated radiotherapy and intensity modulated proton therapy in the treatment of recurrent nasopharyngeal carcinoma.
Hung HM; Chan OCM; Mak CH; Hung WM; Ng WT; Lee MCH
Med Dosim; 2022 Spring; 47(1):14-19. PubMed ID: 34470708
[TBL] [Abstract][Full Text] [Related]
59. PTV-based VMAT vs. robust IMPT for head-and-neck cancer: A probabilistic uncertainty analysis of clinical plan evaluation with the Dutch model-based selection.
Rojo-Santiago J; Korevaar E; Perkó Z; Both S; Habraken SJM; Hoogeman MS
Radiother Oncol; 2023 Sep; 186():109729. PubMed ID: 37301261
[TBL] [Abstract][Full Text] [Related]
60. Technical Note: Treatment planning system (TPS) approximations matter - comparing intensity-modulated proton therapy (IMPT) plan quality and robustness between a commercial and an in-house developed TPS for nonsmall cell lung cancer (NSCLC).
Liu C; Yu NY; Shan J; Bhangoo RS; Daniels TB; Chiang JS; Ding X; Lara P; Patrick CL; Archuleta JP; DeWees T; Hu Y; Schild SE; Bues M; Sio TT; Liu W
Med Phys; 2019 Nov; 46(11):4755-4762. PubMed ID: 31498885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
